Esophageal muscle biopsy for Achalasia
This trial will study how well a new technology can measure muscle fibrosis in people with achalasia. A better understanding of achalasia will allow intervention at an earlier stage.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any risks associated with obtaining an esophageal muscle biopsy?
"Thanks to clinical data collected during Phase 4, esophageal muscle biopsy was awarded a score of 3 in terms of safety."
Could you please provide a list of pertinent investigations that have utilized Esophageal muscle biopsy?
"Currently, 22 active medical trials exploring Esophageal muscle biopsy exist with 6 of them in Phase 3. These studies are largely situated within Shanghai but there is representation from 149 total sites across the globe."
What is the population size accepted for this research endeavor?
"Affirmative. Based on the information provided by clinicaltrials.gov, this medical trial is seeking 80 participants from a single location and has been open for recruitment since March 17th 2021 with the latest update being posted on March 9th 2022."
Are researchers recruiting participants for this study currently?
"Clinicaltrials.gov confirms that the trial is actively enrolling participants, with first posting on March 17th 2021 and most recent edit of March 9th 2022."